[Click eStock] "E&Di, Full Reflection of Precursor Sales for Small Injection Molding Next Year"

IBK Investment & Securities Report

[Asia Economy Reporter Minji Lee] On the 29th, IBK Investment & Securities projected that sales of small particle size precursors related to secondary batteries by E&Di will be fully reflected starting next year.

The demand in the high-performance secondary battery market is rapidly increasing due to the launch of high-performance electric vehicles and the expansion of electric vehicle adoption rates. Cathode materials are a key component accounting for 40% of the production cost of secondary batteries, and recently, global electric vehicle manufacturers have shown growing interest in developing high-nickel cathode materials with increased nickel content.

E&Di's competitive edge lies in its internalized global-level catalyst technology. Most of the DPF systems attached to domestic diesel vehicles are either produced by the company or use the company's catalysts. The biggest competitive advantage that allowed the company to secure a high market share in the DPF system industry is its global-level internalized catalyst technology.

Researcher Geon-Dae Lee of IBK Investment & Securities explained, "The company has succeeded in developing small particle size precursors used in secondary batteries through its independently secured catalyst technology and is currently focusing all efforts on expanding production facilities. Small particle size precursors attract significant market interest because when mixed with large particle size precursors, which are currently imported from China, they enable the production of secondary batteries with high energy density."

Recently, the company increased its planned investment in production facilities for small particle size precursors by about 40%, from 15 billion KRW to 21 billion KRW, according to a revised disclosure. Researcher Lee said, "As the best measure to quickly respond to market demand, after the completion of production facility investment in the first quarter of next year, the company will go through a facility stabilization phase and then fully reflect sales of small particle size precursors starting from the third quarter of next year."

This content was produced with the assistance of AI translation services.